Fortive Corporation · FTV · FY2026 Q2 · Calendar Q3 2026
Fortive Q2: 6.7% Core Growth and Higher EPS Guidance
Fortive's Q2 results support a constructive operating trajectory: core growth accelerated, profitability grew faster than revenue, and management raised adjusted EPS guidance. The case still depends on converting AI-enabled products and recurring-revenue initiatives into durable top-line and margin gains while managing mix, tariff, inflation, and healthcare-spending risks.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about FTV FY2026 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter's analysis, Fortive reported faster 6.7% core revenue growth, raised full-year adjusted EPS guidance, and added new developments including a majority-stake investment in UV Smart, FDA clearance for a 50-pound STERRAD load capacity, and a $4.5 million IEEPA tariff refund. Management continued to emphasize AI-enabled products, recurring revenue, data-center and defense exposure, and disciplined bolt-on M&A.
Guidance delta
Management raised full-year adjusted EPS guidance to $2.95-$3.05, versus $2.90-$3.00 previously.
Key takeaways
- Q2 core revenue grew 6.7% year over year, while adjusted EBITDA increased 12% and adjusted EPS increased 28%.
- AI-enabled products, recurring revenue, and targeted end-market investment were central growth themes.
- Fortive continued share repurchases, acquired a majority stake in UV Smart, and received a $4.5 million IEEPA tariff refund.
- Management cited mix-shift pressure and macroeconomic uncertainty, particularly in EMEA, as ongoing constraints.
Management priorities
- Scale the AI Center of Excellence and embed AI across software brands.
- Expand commercial intensity for Fluke in data-center and defense markets.
- Integrate UV Smart technology into ASP offerings.
- Continue disciplined capital allocation across organic investment, bolt-on M&A, repurchases, and dividends.
- Expand recurring revenue through services, software subscriptions, and maintenance contracts.
Follow FTV with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 23, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Argus Research | Buy | Buy | Maintain | Aug 19, 2026 |
| Truist Securities | Hold | Hold | Maintain | Jul 30, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 3, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | May 12, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 4, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | May 1, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 1, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Feb 9, 2026 |
| Mizuho | Underperform | Outperform | Downgrade | Jan 5, 2026 |
| Baird | Outperform | Outperform | Maintain | Nov 4, 2025 |
| TD Cowen | Hold | Buy | Downgrade | Jul 15, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Jul 1, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Sep 6, 2024 |
| Vertical Research | Hold | Buy | Downgrade | Jan 2, 2024 |
| B of A Securities | Neutral | Buy | Downgrade | Oct 26, 2023 |
| UBS | Buy | Buy | Maintain | Oct 10, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Oct 27, 2022 |
| Loop Capital | Buy | Buy | Maintain | Jul 19, 2022 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Jun 2, 2022 |
| Rosenblatt | Neutral | Neutral | Maintain | May 4, 2021 |
| Bank of America | Buy | Buy | Maintain | Sep 5, 2019 |
| Gordon Haskett | Hold | Buy | Downgrade | Aug 5, 2019 |
| Berenberg | Buy | Buy | Maintain | May 15, 2019 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 26, 2019 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Oct 29, 2018 |
| Argus | Buy | Buy | Maintain | Aug 14, 2018 |
| Stifel Nicolaus | Hold | Hold | Maintain | Oct 27, 2017 |
| Stifel | Hold | Hold | Maintain | Oct 27, 2017 |
| Oppenheimer | Perform | Perform | Maintain | Jan 18, 2017 |
| Goldman Sachs | Neutral | Neutral | Maintain | Sep 29, 2016 |
Named analyst price targets
Upside is calculated against the persisted current price $56.26. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $67 | $61.8 | +19.1% | Jul 2, 2026 |
| Morgan Stanley | Analyst unavailable | $59 | $60.59 | +4.9% | Jun 3, 2026 |
| Argus Research | John Eade | $68 | $60.79 | +20.9% | May 11, 2026 |
| Truist Financial | Analyst unavailable | $61 | $60.73 | +8.4% | May 4, 2026 |
| Truist Financial | Analyst unavailable | $56 | $60.38 | -0.5% | Apr 20, 2026 |
| Barclays | Analyst unavailable | $63 | $60.12 | +12.0% | Feb 9, 2026 |
| Seaport Global | Analyst unavailable | $70 | $60.24 | +24.4% | Feb 5, 2026 |
| Robert W. Baird | Analyst unavailable | $65 | $60.13 | +15.5% | Feb 5, 2026 |
| Mizuho Securities | Analyst unavailable | $51 | $55.39 | -9.3% | Jan 5, 2026 |
| Wells Fargo | Joseph O'Dea | $59 | $54.91 | +4.9% | Dec 22, 2025 |
| Robert W. Baird | Robert Mason | $58 | $50.14 | +3.1% | Nov 4, 2025 |
| Truist Financial | Analyst unavailable | $58 | $51.38 | +3.1% | Oct 30, 2025 |
| Seaport Global | Analyst unavailable | $66 | $52.44 | +17.3% | Oct 30, 2025 |
| Barclays | Analyst unavailable | $56 | $50.34 | -0.5% | Oct 30, 2025 |
| Mizuho Securities | Brett Linzey | $54 | $48.69 | -4.0% | Oct 17, 2025 |
| Barclays | Julian Mitchell | $54 | $48.73 | -4.0% | Aug 14, 2025 |
| Truist Financial | Jamie Cook | $55 | $49.65 | -2.2% | Jul 31, 2025 |
| Citigroup | Ronald Josey | $40 | $51.15 | -28.9% | Jul 15, 2025 |
| Barclays | Analyst unavailable | $85 | $75.93 | +51.1% | Mar 26, 2025 |
| Wells Fargo | Joseph O'Dea | $80 | $76.65 | +42.2% | Jan 7, 2025 |
| Truist Financial | Jamie Cook | $90 | $78.32 | +60.0% | Dec 19, 2024 |
| UBS | Amit Mehrotra | $84 | $68.88 | +49.3% | Nov 13, 2024 |
| Barclays | Julian Mitchell | $98 | $77.6 | +74.2% | Oct 2, 2024 |
| Morgan Stanley | Christopher Snyd | $89 | $72.8 | +58.2% | Sep 6, 2024 |
| Mizuho Securities | Brett Linzey | $90 | $72.8 | +60.0% | Sep 6, 2024 |
| Barclays | Julian Mitchell | $94 | $72.88 | +67.1% | Sep 5, 2024 |
| Raymond James | Brian Gesuale | $85 | $72.86 | +51.1% | Sep 5, 2024 |
| Robert W. Baird | Richard Eastman | $85 | $73.04 | +51.1% | Sep 5, 2024 |
| Seaport Global | Scott Graham | $88 | $70.44 | +56.4% | Jul 25, 2024 |
| RBC Capital | Deane Dray | $77 | $70.4 | +36.9% | Jul 25, 2024 |
| Barclays | Julian Mitchell | $93 | $72.64 | +65.3% | Jul 10, 2024 |
| Argus Research | John Eade | $85 | $77.06 | +51.1% | May 13, 2024 |
| Wells Fargo | Joseph O'Dea | $84 | $76.05 | +49.3% | Apr 25, 2024 |
| RBC Capital | Deane Dray | $83 | $76.05 | +47.5% | Apr 25, 2024 |
| RBC Capital | Deane Dray | $93 | $83.77 | +65.3% | Apr 4, 2024 |
| Truist Financial | Jamie Cook | $99 | $85.46 | +76.0% | Mar 13, 2024 |
| Citigroup | Analyst unavailable | $77 | $65.72 | +36.9% | Dec 9, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $73 | $59.95 | +29.8% | Oct 12, 2022 |
| Barclays | Julian Mitchell | $72 | $65.28 | +28.0% | Aug 4, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $64 | $63 | +13.8% | Jun 7, 2022 |
| Wells Fargo | Analyst unavailable | $65 | $58.33 | +15.5% | Apr 29, 2022 |
| RBC Capital | Analyst unavailable | $65 | $58.56 | +15.5% | Apr 29, 2022 |
| Barclays | Julian Mitchell | $75 | $61.9 | +33.3% | Mar 18, 2022 |
| Robert W. Baird | Robert Mason CFA | $81 | $64.32 | +44.0% | Feb 4, 2022 |
| Mizuho Securities | Brett Linzey | $82 | $72.16 | +45.8% | Jan 19, 2022 |
| Vertical Research | Jeffrey Sprague | $82 | $73.49 | +45.8% | Jan 3, 2022 |
| Loop Capital Markets | Scott Graham | $90 | $78.5 | +60.0% | Nov 22, 2021 |
| Credit Suisse | John Walsh | $87 | $75.56 | +54.6% | Oct 29, 2021 |
| Wolfe Research | Nigel Coe | $84 | $70.24 | +49.3% | Jul 12, 2021 |
| UBS | Markus Mittermaier | $86 | $72.16 | +52.9% | May 6, 2021 |
Track every rating change on FTV the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationFortive Corporation is a global industrial technology company that specializes in the conception, development, manufacturing, marketing, and servicing of sophisticated professional and engineered products, as well as software platforms and associated services. Its Intelligent Operating Solutions division aims to boost efficiency and safety in operations. This segment delivers a variety of offerings, including advanced tools for ensuring equipment reliability, comprehensive enterprise software for managing environmental, health, safety, and quality (EHSQ) compliance, and specialized software for the entire lifecycle of facilities and assets. It also provides solutions for pre-construction planning and procurement, robust professional testing instruments, precise calibration tools for electrical, pressure, and temperature measurements, and portable devices for gas detection.…
Historical context
All FTV earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| ADBE Adobe Inc. | FY2026 Q3 · Calendar Q3 2026 | +0.8% | +1.4% | Adobe raises FY26 outlook as AI strategy broadens |
| ORCL Oracle Corporation | FY2027 Q1 · Calendar Q3 2026 | +10.3% | -1.7% | Oracle raises FY27 outlook as AI demand accelerates cloud growth |
| SAIL SailPoint, Inc. | FY2027 Q2 · Calendar Q3 2026 | +13.8% | -1.2% | SailPoint pairs 25% ARR growth with accelerating AI-driven adoption |
| CIEN Ciena Corporation | FY2026 Q3 · Calendar Q3 2026 | +22.0% | -10.4% | Ciena raises outlook as AI networking demand lifts backlog |
| DOCU DocuSign, Inc. | FY2027 Q2 · Calendar Q3 2026 | +6.4% | +3.7% | DocuSign Q2 FY27: IAM momentum supports a raised outlook |
| IOT Samsara Inc. | FY2027 Q2 · Calendar Q3 2026 | +25.0% | +3.7% | Samsara: AI adoption expands as FY27 guidance holds |
Latest beats and misses
Who reports nextBeat on EPS
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
Get the FTV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-07-29T20:05:56.372889+00:00
- FN2 earnings calendar · 2026-09-03T01:23:14.877038+00:00
- Polygon adjusted daily market bars · 2026-09-23T19:10:55.907041+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-23T19:10:55.904284+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-23. For educational purposes only; not investment advice.